Literature DB >> 16273780

The Health Assessment Questionnaire (HAQ).

B Bruce1, J F Fries.   

Abstract

Patient-reported outcomes (PROs) provide intrinsic knowledge about a patient's health, functional status, symptoms, treatment preferences, satisfaction, and quality of life. They have become an established approach for assessing health outcomes. The Health Assessment Questionnaire (HAQ), introduced in 1980, is among the first PRO instruments designed to represent a model of patient-oriented outcome assessment. The HAQ is based on five patient-centered dimensions: disability, pain, medication effects, costs of care, and mortality. It has been validated by mail, in the office, by telephone, and by comparison with paraprofessional and physician judgments as a reliable instrument, and has been significantly correlated with other PRO instruments. Typically, one of two HAQ versions is used: the Full HAQ, which assesses all five dimensions, and the Short or 2-page HAQ, which contains only the HAQ disability index (HAQ-DI) and the HAQ's patient global and pain visual analog scales (VAS). The HAQ-DI and the global and pain VAS (i.e., the short HAQ) have essentially retained their original content since their inception, while the Full HAQ undergoes periodic revision to address issues of contemporary scientific interest. The HAQ-DI has been translated or culturally adapted into more than 60 different languages or dialects and has become part of the National Institutes of Health "Road-map" Project, the Patient-Reported Outcomes Measurement Information System (PROMIS).

Entities:  

Mesh:

Year:  2005        PMID: 16273780

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  211 in total

1.  Cultural comparison of chronic conditions, functional status, and acceptance in older African-American and White adults.

Authors:  Patricia E McDonald; Jaclene A Zauszniewski; Abir K Bekhet
Journal:  J Natl Black Nurses Assoc       Date:  2010-07

2.  Pulmonary involvement in early rheumatoid arthritis patients.

Authors:  Hisham M Habib; Ashraf A Eisa; Waleed R Arafat; Mohamed A Marie
Journal:  Clin Rheumatol       Date:  2010-05-26       Impact factor: 2.980

3.  Muscle Power Is an Independent Determinant of Pain and Quality of Life in Knee Osteoarthritis.

Authors:  Kieran F Reid; Lori Lyn Price; William F Harvey; Jeffrey B Driban; Cynthia Hau; Roger A Fielding; Chenchen Wang
Journal:  Arthritis Rheumatol       Date:  2015-12       Impact factor: 10.995

4.  Association of Light-Intensity Physical Activity With Lower Cardiovascular Disease Risk Burden in Rheumatoid Arthritis.

Authors:  Samannaaz S Khoja; Gustavo J Almeida; Mary Chester Wasko; Lauren Terhorst; Sara R Piva
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-04       Impact factor: 4.794

5.  [Multimorbidity and successful aging: the population-based KORA-Age study].

Authors:  A Peters; A Döring; K-H Ladwig; C Meisinger; B Linkohr; C Autenrieth; S E Baumeister; J Behr; A Bergner; H Bickel; M Bidlingmaier; A Dias; R T Emeny; B Fischer; E Grill; L Gorzelniak; H Hänsch; S Heidbreder; M Heier; A Horsch; D Huber; R M Huber; R A Jörres; S Kääb; S Karrasch; I Kirchberger; G Klug; B Kranz; B Kuch; M E Lacruz; O Lang; A Mielck; D Nowak; S Perz; A Schneider; H Schulz; M Müller; H Seidl; R Strobl; B Thorand; R Wende; W Weidenhammer; A-K Zimmermann; H-E Wichmann; R Holle
Journal:  Z Gerontol Geriatr       Date:  2011-12       Impact factor: 1.281

6.  Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Authors:  Zrinka Jajić; Ivana Rajnpreht; Nataša Kovačić; Ivan Krešimir Lukić; Vedran Velagić; Frane Grubišić; Ana Marušić; Danka Grčević
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

7.  Use of SNOMED CT to represent clinical research data: a semantic characterization of data items on case report forms in vasculitis research.

Authors:  Rachel L Richesson; James E Andrews; Jeffrey P Krischer
Journal:  J Am Med Inform Assoc       Date:  2006-06-23       Impact factor: 4.497

8.  Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial.

Authors:  Jeong Lan Kim; Shilpa Rele; David M Marks; Prakash S Masand; Pallavi Yerramsetty; Robert A Millet; Richard S Keefe; Ashwin A Patkar
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-26

9.  Real-life effectiveness of spa therapy in rheumatic and musculoskeletal diseases: a retrospective study of 819 patients.

Authors:  Mine Karagülle; Sinan Kardeş; Müfit Zeki Karagülle
Journal:  Int J Biometeorol       Date:  2017-05-30       Impact factor: 3.787

10.  Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.

Authors:  Pamela L Wolters; Staci Martin; Vanessa L Merker; James H Tonsgard; Sondra E Solomon; Andrea Baldwin; Amanda L Bergner; Karin Walsh; Heather L Thompson; Kathy L Gardner; Cynthia M Hingtgen; Elizabeth Schorry; William N Dudley; Barbara Franklin
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.